share_log

Veru shares are trading higher after the company announced it received FDA agreement to advance VERU-111 into Phase 3 study in hospitalized COVID-19 patients at high risk for acute respiratory distres

Veru shares are trading higher after the company announced it received FDA agreement to advance VERU-111 into Phase 3 study in hospitalized COVID-19 patients at high risk for acute respiratory distres

在该公司宣布收到食品和药物管理局的协议,将VERU-111提前到第三阶段研究后,VERU的股价上涨,该研究针对新冠肺炎住院的急性呼吸窘迫高危患者。
Benzinga ·  2021/03/01 22:05

Veru shares are trading higher after the company announced it received FDA agreement to advance VERU-111 into Phase 3 study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome.

在该公司宣布收到食品和药物管理局的协议,将VERU-111提前进入第三阶段研究后,VERU的股价正在上涨。VERU-111是住院的新冠肺炎患者中急性呼吸窘迫综合征的高危患者。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发